Literature DB >> 20358203

Assessment of latent tuberculosis infection in Takayasu arteritis with tuberculin skin test and Quantiferon-TB Gold test.

Omer Karadag1, Kenan Aksu, Abdurrahman Sahin, Figen Yargucu Zihni, Burcin Sener, Nevsun Inanc, Umut Kalyoncu, Sibel Zehra Aydin, Sibel Ascioglu, Pinar Talu Ocakci, Sule Apras Bilgen, Gokhan Keser, Vedat Inal, Haner Direskeneli, Meral Calguneri, Ihsan Ertenli, Sedat Kiraz.   

Abstract

A possible relationship between Takayasu arteritis (TA) and tuberculosis (TB) has been suggested. An increased frequency of tuberculin skin test (TST) was observed in TA patients. Quantiferon-TB Gold test (QFT) is a new in vitro assay measuring interferon-gamma response to M. tuberculosis antigens and helpful in diagnosing latent TB infection. The aim of this study was to investigate latent TB infection among TA patients by the use of both TST and QFT Gold test. Ninety-four (male/female: 7/87) TA patients fulfilling ACR 1990 TA criteria from three different university hospitals in Turkey and 107 control subjects without inflammatory diseases were included in the study. Data about medical history (TA and TB) were collected for both groups. TST and QFT were performed. TST values > or =5 mm for TA patients and > or =15 mm for controls was accepted as TST positivity. Even though TA group was older (40 +/- 12 vs. 32 +/- 8, P < 0.001), there was no significant difference between TA patients and controls regarding demographic characteristics. Six TA patients and one control had a history of previous TB infection (P = 0.054). Although TST positivity was higher in TA group [55 patients (62.5%) vs. 24 controls (41.4%), P = 0.008], QFT positivity was similar between two groups [21 patients (22.3%) vs. 24 controls (22.4%), P > 0.05]. QFT was negative in two of six TA patients with previous TB history. Rate of latent TB infection in TA patients measured with QFT is no more than controls. QFT seems to be a good and favorable test compared with TST in detecting LTBI in TA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20358203     DOI: 10.1007/s00296-010-1444-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  18 in total

1.  Diagnostic accuracy of Quantiferon TB test for patients with SLE and miliary tuberculosis.

Authors:  Mukaddes Tozlu; Umut Kalyoncu; Sehnaz Alp; Serhat Unal; Meral Calguneri
Journal:  Rheumatol Int       Date:  2009-06-04       Impact factor: 2.631

2.  The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis.

Authors:  W P Arend; B A Michel; D A Bloch; G G Hunder; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt; J T Lie; R W Lightfoot
Journal:  Arthritis Rheum       Date:  1990-08

3.  [Takayasu's disease in Morocco. Report of 47 cases].

Authors:  A el Asri; Z Tazi-Mezalek; M Aouni; M Adnaoui; A Mohattane; Y Bensaid; A Maaouni
Journal:  Rev Med Interne       Date:  2002-01       Impact factor: 0.728

4.  Cellular immune responses to Mycobacterium tuberculosis in a patient with Takayasu's arteritis.

Authors:  M F Moraes; D Ordway; L Oliveira; I L Costa; R Badura; M N Pinheiro; J M da Graça; F A Ventura
Journal:  Rev Port Cardiol       Date:  1999-04       Impact factor: 1.374

5.  Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis.

Authors:  Gary S Hoffman; Peter A Merkel; Richard D Brasington; Deborah J Lenschow; Patrick Liang
Journal:  Arthritis Rheum       Date:  2004-07

6.  QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases.

Authors:  F Bartalesi; S Vicidomini; D Goletti; C Fiorelli; G Fiori; D Melchiorre; E Tortoli; A Mantella; M Benucci; E Girardi; M M Cerinic; A Bartoloni
Journal:  Eur Respir J       Date:  2008-12-01       Impact factor: 16.671

Review 7.  Tuberculosis in patients with systemic rheumatic or pulmonary diseases treated with glucocorticosteroids and the preventive role of isoniazid: a review of the available evidence.

Authors:  Matthew E Falagas; Paraskevi T Voidonikola; Anna G Angelousi
Journal:  Int J Antimicrob Agents       Date:  2007-10-29       Impact factor: 5.283

Review 8.  Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy.

Authors:  Ajit Lalvani
Journal:  Chest       Date:  2007-06       Impact factor: 9.410

Review 9.  Novel screening tools for latent tuberculosis: time to leave an old friend?

Authors:  Peter M Villiger; Jean-Pierre Zellweger; Burkhard Möller
Journal:  Curr Opin Rheumatol       Date:  2009-05       Impact factor: 5.006

10.  Takayasu arteritis.

Authors:  G S Kerr; C W Hallahan; J Giordano; R Y Leavitt; A S Fauci; M Rottem; G S Hoffman
Journal:  Ann Intern Med       Date:  1994-06-01       Impact factor: 25.391

View more
  13 in total

1.  Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda.

Authors:  Haner Direskeneli; Sibel Z Aydin; Tanaz A Kermani; Eric L Matteson; Maarten Boers; Karen Herlyn; Raashid A Luqmani; Tuhina Neogi; Philip Seo; Ravi Suppiah; Gunnar Tomasson; Peter A Merkel
Journal:  J Rheumatol       Date:  2011-07       Impact factor: 4.666

2.  Absence of mycobacterial DNA in peripheral blood and artery specimens in patients with Takayasu arteritis.

Authors:  Evanir S Carvalho; Alexandre W S de Souza; Sylvia Cardoso Leão; Maurício Levy-Neto; Rosangela Siqueira de Oliveira; Wonder Drake; Marcello Fabiano de Franco; Paulo H N Saldiva; Paulo Sampaio Gutierrez; Luís Eduardo C Andrade
Journal:  Clin Rheumatol       Date:  2016-09-07       Impact factor: 2.980

3.  Association between Takayasu arteritis and latent or active Mycobacterium tuberculosis infection: a systematic review.

Authors:  Ana Luisa S Pedreira; Mittermayer B Santiago
Journal:  Clin Rheumatol       Date:  2019-11-15       Impact factor: 2.980

4.  Comparison of clinical characteristics in patients with Takayasu arteritis with and without concomitant tuberculosis.

Authors:  A Young Lim; Ga Yeon Lee; Shin Yi Jang; Hye Bin Gwag; Seung Hyuk Choi; Eun-Seok Jeon; Hoon-Suk Cha; Kiick Sung; Young-Wook Kim; Sung Mok Kim; Yeon Hyeon Choe; Won-Jung Koh; Duk-Kyung Kim
Journal:  Heart Vessels       Date:  2015-08-13       Impact factor: 2.037

5.  Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis.

Authors:  Tan N Doan; Damon P Eisen; Morgan T Rose; Andrew Slack; Grace Stearnes; Emma S McBryde
Journal:  PLoS One       Date:  2017-11-28       Impact factor: 3.240

Review 6.  Is Takayasu arteritis the result of a Mycobacterium tuberculosis infection? The use of TNF inhibitors may be the proof-of-concept to demonstrate that this association is epiphenomenal.

Authors:  Diana Castillo-Martínez; Luis M Amezcua-Castillo; Julio Granados; Carlos Pineda; Luis M Amezcua-Guerra
Journal:  Clin Rheumatol       Date:  2020-03-20       Impact factor: 2.980

7.  Stroke as the Sole Manifestation of Takayasu Arteritis in a 15-Year-Old Boy with Latent Tuberculosis.

Authors:  Espen Benjaminsen; Anne Reigstad; Vanja Cengija; Vibke Lilleby; Maria Carlsson
Journal:  Case Rep Neurol Med       Date:  2016-11-14

8.  High Secretion of Interleukin-6 and Increased MINCLE Receptor Expression Upon Exposure to Mycobacterial Cord Factor Analog Trehalose-6, 6-Dibehenate (TDB) in Patients with Takayasu Arteritis.

Authors:  Nikhil Gupta; Jayakanthan Kabeerdoss; Hindhumathi Mohan; Ruchika Goel; Debashish Danda
Journal:  Open Rheumatol J       Date:  2018-03-28

Review 9.  New Insights on the Pathogenesis of Takayasu Arteritis: Revisiting the Microbial Theory.

Authors:  J Luis Espinoza; Suzue Ai; Itaru Matsumura
Journal:  Pathogens       Date:  2018-09-06

10.  Takayasu Arteritis Associated with Latent Tuberculosis Infection: A 39-Year-Old Woman Is the First Case in Gabon.

Authors:  Guignali Laurette Mangouka; Berthe Amélie Iroungou; Berthold Bivigou-Mboumba; Davy Ngabou; El Medhi Badidi Moulay; Abdelatif Darbi; Jean Raymond Nzenze
Journal:  Am J Case Rep       Date:  2020-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.